Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Jewish Home Lifecare
mi
from
New York, NY
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Jewish Home Lifecare
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
Avera McKennan Hospital and University Health Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated:  9/29/2015
CenVaNet
mi
from
Richmond, VA
Evaluation of Programs of Coordinated Care and Disease Management
Evaluation of Programs of Coordinated Care and Disease Management
Status: Enrolling
Updated: 9/29/2015
CenVaNet
mi
from
Richmond, VA
Click here to add this to my saved trials
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
Role of Caspase-3, Phosphatidylinositol-3 Kinase (PI3K), and 3-methylhistidine (3-MH) in the Pathophysiology of Skeletal Muscle Loss in Weight-losing Pancreas Cancer Patients
Status: Enrolling
Updated:  9/29/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
Role of Caspase-3, Phosphatidylinositol-3 Kinase (PI3K), and 3-methylhistidine (3-MH) in the Pathophysiology of Skeletal Muscle Loss in Weight-losing Pancreas Cancer Patients
Status: Enrolling
Updated: 9/29/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Psychosocial Adjustment During the Post-Radiation Treatment Transition
Status: Enrolling
Updated:  9/29/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Psychosocial Adjustment After Radiation Therapy in Patients With Cancer
Psychosocial Adjustment During the Post-Radiation Treatment Transition
Status: Enrolling
Updated: 9/29/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
Pilot Trial of Pioglitazone in Adults Undergoing Surgical Resection of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  9/29/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
Pilot Trial of Pioglitazone in Adults Undergoing Surgical Resection of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 9/29/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
Pilot Trial of Pioglitazone in Adults Undergoing Surgical Resection of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  9/29/2015
New York University
mi
from
New York, NY
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
Pilot Trial of Pioglitazone in Adults Undergoing Surgical Resection of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 9/29/2015
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
Comparison of Flocked vs. Dacron Swab for Anal Cytology, Correspondence With High Resolution Anoscopy
Status: Enrolling
Updated:  9/30/2015
UCLA
mi
from
Los Angeles, CA
Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
Comparison of Flocked vs. Dacron Swab for Anal Cytology, Correspondence With High Resolution Anoscopy
Status: Enrolling
Updated: 9/30/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated:  9/30/2015
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated: 9/30/2015
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated:  9/30/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated: 9/30/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated:  9/30/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
Status: Enrolling
Updated: 9/30/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Colorado, School of Medicine
mi
from
Aurora, CO
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Colorado, School of Medicine
mi
from
Aurora, CO
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Denver VA Medical Center-ECHCS
mi
from
Denver, CO
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Denver VA Medical Center-ECHCS
mi
from
Denver, CO
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Pennslvania Abramson Cancer Center
mi
from
Philadelphia, PA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Pennslvania Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Stanford Cancer Institute
mi
from
Stanford, CA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Stanford Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Veterans Administration New Jersey Health Care System
mi
from
East Orange, NJ
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Veterans Administration New Jersey Health Care System
mi
from
East Orange, NJ
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Montefiore Medical Center
mi
from
Bronx, NY
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Mount Sinai Hospital
mi
from
New York, NY
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
The Ohio State University James Cancer Hospital
mi
from
Columbus, OH
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
The Ohio State University James Cancer Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Blue Ridge Cancer Care
mi
from
Salem, VA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Blue Ridge Cancer Care
mi
from
Salem, VA
Click here to add this to my saved trials
Treatment Preference and Patient Centered Prostate Cancer Care
Treatment Preference and Patient Centered Prostate Cancer Care
Status: Enrolling
Updated:  9/30/2015
Philadelphia Veterans Affairs Medical Center
mi
from
Philadelphia, PA
Treatment Preference and Patient Centered Prostate Cancer Care
Treatment Preference and Patient Centered Prostate Cancer Care
Status: Enrolling
Updated: 9/30/2015
Philadelphia Veterans Affairs Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Treatment Preference and Patient Centered Prostate Cancer Care
Treatment Preference and Patient Centered Prostate Cancer Care
Status: Enrolling
Updated:  9/30/2015
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Treatment Preference and Patient Centered Prostate Cancer Care
Treatment Preference and Patient Centered Prostate Cancer Care
Status: Enrolling
Updated: 9/30/2015
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Treatment Preference and Patient Centered Prostate Cancer Care
Treatment Preference and Patient Centered Prostate Cancer Care
Status: Enrolling
Updated:  9/30/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Treatment Preference and Patient Centered Prostate Cancer Care
Treatment Preference and Patient Centered Prostate Cancer Care
Status: Enrolling
Updated: 9/30/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated:  9/30/2015
Medical Oncology and Hematology Associates of Northern Virginia
mi
from
Fairfax, VA
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated: 9/30/2015
Medical Oncology and Hematology Associates of Northern Virginia
mi
from
Fairfax, VA
Click here to add this to my saved trials
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated:  9/30/2015
Medical Oncology & Hematology Associates of Northern Virginia
mi
from
Reston, VA
Prevention of Paclitaxel Neuropathy With Cryotherapy
Prevention of Paclitaxel Neuropathy With Cryotherapy
Status: Enrolling
Updated: 9/30/2015
Medical Oncology & Hematology Associates of Northern Virginia
mi
from
Reston, VA
Click here to add this to my saved trials
Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
A Phase II Study of Whole Blood Hyperthermia and Ice Chemotherapy in Sarcoma Patients
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
A Phase II Study of Whole Blood Hyperthermia and Ice Chemotherapy in Sarcoma Patients
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer
Status: Enrolling
Updated:  9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer
Status: Enrolling
Updated: 9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer
Status: Enrolling
Updated:  9/30/2015
Wilshire Oncology Medical Group
mi
from
Rancho Cucamonga, CA
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer
Status: Enrolling
Updated: 9/30/2015
Wilshire Oncology Medical Group
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases
Prognostic Factors Associated With Successful Omission of Whole Brain Radiotherapy in Patients With 4 or Less Cerebral Metastases Treated With Focal Radiation or Surgery
Status: Enrolling
Updated:  9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases
Prognostic Factors Associated With Successful Omission of Whole Brain Radiotherapy in Patients With 4 or Less Cerebral Metastases Treated With Focal Radiation or Surgery
Status: Enrolling
Updated: 9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
Phase I Study of Endostatin in Advanced Cancer Patients
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
Phase I Study of Endostatin in Advanced Cancer Patients
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Liver Cancer
Phase I/II Trial Testing Alpha Fetoprotein (AFP) Peptide Immunization in Hepatocellular Carcinoma
Status: Enrolling
Updated:  9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Vaccine Therapy in Treating Patients With Liver Cancer
Phase I/II Trial Testing Alpha Fetoprotein (AFP) Peptide Immunization in Hepatocellular Carcinoma
Status: Enrolling
Updated: 9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
An Open Label, Sequential Multi-Center Multi Dose Study Of G17T Immunogen In Combination With Cisplatin (CDDP) And 5-Fluorouracil (5-FU) In Subjects With Metastatic Or Locally Recurrent Gastric Or Gastroesophageal Cancer Previously Untreated With Chemotherapy For Advanced Disease (Stage IV)
Status: Enrolling
Updated:  9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
An Open Label, Sequential Multi-Center Multi Dose Study Of G17T Immunogen In Combination With Cisplatin (CDDP) And 5-Fluorouracil (5-FU) In Subjects With Metastatic Or Locally Recurrent Gastric Or Gastroesophageal Cancer Previously Untreated With Chemotherapy For Advanced Disease (Stage IV)
Status: Enrolling
Updated: 9/30/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
A Phase I and Pharmacodynamic Study of Proteasome Inhibitor, PS-341, in Combination With Doxorubicin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
A Phase I and Pharmacodynamic Study of Proteasome Inhibitor, PS-341, in Combination With Doxorubicin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases
Treament of Spontaneous Tumor Metastases With IL-12 DNA (NSC #709933): A Phase IB Trial
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases
Treament of Spontaneous Tumor Metastases With IL-12 DNA (NSC #709933): A Phase IB Trial
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated:  9/30/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated: 9/30/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix
Preservation of Ovarian Function Via Laparoscopic Transposition in Patients With Locally Advanced Squamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin
mi
from
Madison, WI
Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix
Preservation of Ovarian Function Via Laparoscopic Transposition in Patients With Locally Advanced Squamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer
Laparoscopic Sentinel Lymph Node Localization in Patients With Operable Cervical Cancer - A Pilot Study
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin
mi
from
Madison, WI
Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer
Laparoscopic Sentinel Lymph Node Localization in Patients With Operable Cervical Cancer - A Pilot Study
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Disseminated Endometrial Cancer Cells During Sonohysterography
The Incidence of Disseminated Endometrial Cancer Cells During Sonohysterography and Their Functional Viability: a Prospective Study
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin
mi
from
Madison, WI
Disseminated Endometrial Cancer Cells During Sonohysterography
The Incidence of Disseminated Endometrial Cancer Cells During Sonohysterography and Their Functional Viability: a Prospective Study
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Surveillance For New Lung Primaries
Low Dose Helical Computed Tomographic (CT) Screening Followed by Anatomic Co-Registered Computed Tomography With Positron Emission Tomography (CT/PET) for Patients With Indeterminate (5-9 mm) Nodules
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Surveillance For New Lung Primaries
Low Dose Helical Computed Tomographic (CT) Screening Followed by Anatomic Co-Registered Computed Tomography With Positron Emission Tomography (CT/PET) for Patients With Indeterminate (5-9 mm) Nodules
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Effects of Swallowing Therapy in Head and Neck Cancer
Effects of Swallowing Therapy in Head and Neck Cancer
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin
mi
from
Madison, WI
Effects of Swallowing Therapy in Head and Neck Cancer
Effects of Swallowing Therapy in Head and Neck Cancer
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated:  9/30/2015
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated: 9/30/2015
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated:  9/30/2015
Harvard School of Public Health
mi
from
Boston, MA
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated: 9/30/2015
Harvard School of Public Health
mi
from
Boston, MA
Click here to add this to my saved trials
Vitamin D in Treating Patients With Prostate Cancer
Study of Serum 25(OH) D3 Level Variability in Response to Different Doses of Oral Vitamin D Supplementation in Prostate Cancer Patients
Status: Enrolling
Updated:  9/30/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Vitamin D in Treating Patients With Prostate Cancer
Study of Serum 25(OH) D3 Level Variability in Response to Different Doses of Oral Vitamin D Supplementation in Prostate Cancer Patients
Status: Enrolling
Updated: 9/30/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials